Cargando…

Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia

To investigate the mechanism underlying AT1-AA-induced retinopathy in severe preeclampsia by measuring the positive rate and titer of AT1-AA in plasma from women with severe preeclampsia and normal pregnant women to see whether AT1-AA titer was correlated with the grade of retinopathy. A preeclampsi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fang, Wang, Yuxian, Wang, Xiaofang, Zheng, Yanqian, Jin, Zhu, Zhi, Jianming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933922/ https://www.ncbi.nlm.nih.gov/pubmed/27381670 http://dx.doi.org/10.1038/srep29036

Ejemplares similares

Maternal Treatment with Agonistic Autoantibodies against Type-1 Angiotensin II Receptor in Late Pregnancy Increases Apoptosis of Myocardial Cells and Myocardial Susceptibility to Ischemia-Reperfusion Injury in Offspring Rats
por: Jin, Zhu, et al.
Publicado: (2013)

The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia
por: Irani, Roxanna A., et al.
Publicado: (2009)

Association of Angiotensin Receptor Autoantibodies With Cardiovascular Abnormalities in Preeclampsia
por: Minhas, Anum S., et al.
Publicado: (2021)

Angiotensin II type 1 receptor agonistic autoantibody blockade improves postpartum hypertension and cardiac mitochondrial function in rat model of preeclampsia
por: Booz, George W., et al.
Publicado: (2021)

Role and mechanism of AT1-AA in the pathogenesis of HELLP syndrome
por: Bu, Shurui, et al.
Publicado: (2018)

Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies
por: Zhai, Ruonan, et al.
Publicado: (2022)

Association of Angiotensin II Type 1 Receptor Agonistic Autoantibodies With Outcomes in Patients With Acute Aortic Dissection
por: Wu, Xiao-wei, et al.
Publicado: (2021)

Lipoxin A(4) suppresses angiotensin II type 1 receptor autoantibody in preeclampsia via modulating caspase-1
por: Liu, Haojing, et al.
Publicado: (2020)

Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia
por: Liu, Chen, et al.
Publicado: (2015)

Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism
por: Meyer, Lucie S., et al.
Publicado: (2020)

Large‐Conductance Calcium‐Activated Potassium Channel Opener, NS1619, Protects Against Mesenteric Artery Remodeling Induced by Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor
por: Wang, Meili, et al.
Publicado: (2022)

Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome
por: Yu, Xichun, et al.
Publicado: (2018)

Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma
por: Jünemann, Anselm, et al.
Publicado: (2018)

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
por: Vasile, Silvana, et al.
Publicado: (2020)

Serum agonistic autoantibodies against type-1 angiotensin II receptor titer in patients with epithelial ovarian cancer: a potential role in tumor cell migration and angiogenesis
por: Song, Li, et al.
Publicado: (2013)

Association of autoantibodies against the M2-muscarinic receptor with perinatal outcomes in women with severe preeclampsia
por: Li, Yanfang, et al.
Publicado: (2013)

A novel mechanism of angiotensin II-regulated placental vascular tone in the development of hypertension in preeclampsia
por: Gao, Qinqin, et al.
Publicado: (2017)

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
por: Kill, Angela, et al.
Publicado: (2014)

Antibodies against AT1 Receptors Are Associated with Vascular Endothelial and Smooth Muscle Function Impairment: Protective Effects of Hydroxysafflor Yellow A
por: Jin, Zhu, et al.
Publicado: (2013)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

Endothelium-Dependent Relaxation and Angiotensin II Sensitivity in Experimental Preeclampsia
por: van der Graaf, Anne Marijn, et al.
Publicado: (2013)

SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II
por: Briquez, Priscilla S., et al.
Publicado: (2021)

Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy
por: Adamus, Grazyna, et al.
Publicado: (2004)

Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor
por: Du, Qian, et al.
Publicado: (2013)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Angiotensin Type 2 Receptor Gene Polymorphisms and Susceptibility to Preeclampsia
por: Soltani-Zangbar, Mohammad Sadegh, et al.
Publicado: (2018)

Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2021)

Role of the Uteroplacental Renin–Angiotensin System in Placental Development and Function, and Its Implication in the Preeclampsia Pathogenesis
por: Yart, Lucile, et al.
Publicado: (2021)

PPARγ Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
por: Han, Jee-Young, et al.
Publicado: (2010)

Inhibitory and Agonistic Autoantibodies Directed Against the β(2)-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2021)

Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity
por: Briquez, Priscilla S., et al.
Publicado: (2022)

Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis
por: Wei, Jinjing, et al.
Publicado: (2022)

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
por: Labandeira, Carmen M., et al.
Publicado: (2022)

Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy
por: Wang, Yujuan, et al.
Publicado: (2012)

Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
por: Hohberger, Bettina, et al.
Publicado: (2021)

Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the down-regulation of the androgen receptor
por: Ito, Yusuke, et al.
Publicado: (2018)

Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis
por: Namisaki, Tadashi, et al.
Publicado: (2017)

Three polymorphisms of renin-angiotensin system and preeclampsia risk
por: Wang, Chen, et al.
Publicado: (2020)

The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice
por: Wang, Shuai, et al.
Publicado: (2018)

Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor
por: Miura, Shin-ichiro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kchvfqdrpo1r4udibdsug9okf1